glp-1 obesity drug news updates FDA-approved semaglutide is the first pill for weight loss available in the U.S., according to drugmaker Novo Nordisk The GLP-1 revolution: What UAB
Description
Metabolic Benefits: Along with weight loss, it has shown promising results in treating Type 2 diabetes, with some studies showing hemoglobin A1c reductions
The rise of GLP-1 receptor agonists, such as semaglutide and tirzepatide, has revolutionized weight loss treatmentsbut how do they impact the absorption of other medications
It's unclear whether they should be used together
Find out more here.
Management with fluids, electrolytes, and insulin led to rapid recovery
